skip to main content
  • | Hormonal migraine: what does it mean and what can we do about it?

    Last month, online platform published an article about hormonal migraine. Prof. dr. Terwindt and researcher Britt van der Arend explain the current knowledge in the field of hormones and migraine. They also emphasize the need for further research. With the WHAT!-Study they hope to find a hormone targeted treatment for migraine. Read the full article here (in Dutch).

  • "A trigger or coincidence?", an interview in a Belgian magazine

    Last month, prof. dr. Gisela Terwindt and clinical researchers Iris Verhagen and Britt van der Arend were interviewed by a Belgian magazine called “Goed Gevoel”. They talked about trigger factors in migraine, such as hormones. The WHAT!-Study aims for a better hormone-specific treatment for migraine. Read the full article here (in Dutch).

  • Research reveals the causes of migraine

    A lot of people suffer from migraine. The intensity varies from very mild to severe. Mild attacks are not always recognized as migraines. On a scientific level a lot of questions are left unanswered. Neurologist Gisela Terwindt want to inform people about migraine and aims to find better treatment options. Read the full article here (in Dutch) and read more about the campaign here (in Dutch).

  • Dr. Antoinette Maassen van den Brink wins the VNVA Corrie Hermannprice

    Dr. Antoinette Maassen van den Brink will receive the VNVA (Vereniging Nederlandse Vrouwelijke Artsen) Corrie Hermannprice on the 2nd of October 2021, for her role as pioneer in the research area of migraine and female hormones. Read the full article here (in Dutch).

  • Newspaper: women respond different to medication

    Men and women respond different to medication. Researchers from the Leiden University Medical Center and Erasmus MC discovered that triptans are a good example. Women experience more side effects, for example. Nevertheless, they are prescribed the same dosage as men. Read the full article here (in Dutch).

  • RADAR+ Interview with prof. dr. Terwindt

    Two million Dutch people suffer from migraine, women twice as often as men. Acute medication is less effective in women. Prof. dr. Terwindt from the LUMC: ‘Women with migraine have the right to better answers’. Read the full article here (in Dutch).

  1. Previous
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. 6
  8. 7
  9. 8
  10. Next


van der Arend, BWH, van Casteren, DS, Verhagen, IE et al. Continuous combined oral contraceptive use versus vitamin E in the treatment of menstrual migraine: rationale and protocol of a randomized controlled trial (WHAT!). Trials 25, 123 (2024). PubMed.

Verhagen, IE, de Vries Lentsch, S, van der Arend, BWH, le Cessie, S, MaassenVanDenBrink, A, Terwindt, GM. Both perimenstrual and nonperimenstrual migraine days respond to anti-calcitonin gene-related peptide (receptor) antibodies. Eur J Neurol. 2023; 30: 2117- 2121. PubMed.

Verhagen IE, van der Arend BW, van Casteren DS, et al. Migraine with and without aura in relation to the menstrual cycle and other hormonal milestones: A prospective cohort study. Cephalalgia. 2023;43(6). PubMed.

Verhagen IE, van der Arend BWH, van Casteren DS, le Cessie S,  MaassenVanDenBrink A, Terwindt GM. Sex differences in migraine attack characteristics: A longitudinal E-diary study. Headache. 2023; 63: 333-341. PubMed.

Verhagen IE, Spaink HA, van der Arend BW, van Casteren DS, MaassenVanDenBrink A, Terwindt GM. Validation of diagnostic ICHD-3 criteria for menstrual migraine. Cephalalgia. 2022 Oct; 42(11-12): 1184-1193. PubMed.

Verhagen, I.E., Brandt, R.B., Kruitbosch, C.M.A., MaassenVanDenBrink A, Fronczek R, Terwindt GM. Clinical symptoms of androgen deficiency in men with migraine or cluster headache: a cross-sectional cohort study. Journal of Headache and Pain 22, 125 (2021). PubMed.

van Casteren DS, Verhagen IE, BWH van der Arend, EW van Zwet, MaassenVanDenBrink A, Terwindt GM. Comparing perimenstrual and nonperimenstrual migraine attacks using an E-diary. Neurology. 2021 Sep. PubMed.

van Casteren DS, Verhagen IE, Onderwater GL, MaassenVanDenBrink A, Terwindt GM. Sex differences in prevalence of migraine trigger factors: A cross-sectional study. Cephalalgia. 2021 May; 41(6):643-648. PubMed.

van Casteren DS, Kurth T, Danser AHJ, Terwindt GM, MaassenVanDenBrink A. Sex Differences in Response to Triptans: A Systematic Review and Meta-analysis. Neurology. 2021 Jan 26; 96(4):162-170. PubMed.

van Casteren DS, Verhagen IE, de Boer I, de Vries Lentsch S, Fronczek R, van Zwet EW, MaassenVanDenBrink A, Terwindt GM. E-diary use in clinical headache practice: A prospective observational study. Cephalalgia. 2021 Oct; 41(11-12): 1161-1171. PubMed.

van Casteren DS, van Willigenburg FAC, MaassenVanDenBrink A, Terwindt GM. Jealousy in women with migraine: a cross-sectional case-control study. The Journal of Headache and Pain. May 2020. PubMed.

van Casteren DS, MaassenVanDenBrink A, Terwindt GM. Migraine and other headache disorders in pregnancy. Handbook of Clinical Neurology. 2020. PubMed.